Linked Life Data

17984842

Source:http://linkedlifedata.com/resource/pubmed/id/17984842

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2007-11-6
pubmed:abstractText
FTY720 is a novel immunomodulator that was developed to produce optimal graft protection with improved safety and tolerability. Phase II studies have demonstrated the efficacy of FTY720 up to the doses of 2.5 mg with full-dose cyclosporine (FDC).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0041-1337
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
84
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
885-92
pubmed:dateRevised
2008-6-5
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study.
pubmed:affiliation
Setor de Transplante Renal, Hospital do Rim Hipertensão/ UNIFESP, Rua Borges Lagoa, Sao Paulo, Brazil. heliotedesco@hrim.com.br
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II